Statements (21)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:person
|
| gptkbp:boardMemberOf |
gptkb:Alexion_Pharmaceuticals
|
| gptkbp:education |
gptkb:Yale_School_of_Medicine
gptkb:Yale_University |
| gptkbp:employer |
gptkb:Altos_Labs
|
| gptkbp:fieldOfWork |
gptkb:medicine
pharmaceutical research |
| gptkbp:formerPosition |
gptkb:Genentech
gptkb:Roche GlaxoSmithKline Chief Scientific Officer Executive Vice President, Head of Global Product Development |
| https://www.w3.org/2000/01/rdf-schema#label |
Hal V. Barron
|
| gptkbp:nationality |
gptkb:American
|
| gptkbp:notableWork |
drug development
|
| gptkbp:occupation |
gptkb:business_executive
gptkb:physician gptkb:scientist |
| gptkbp:position |
CEO
|
| gptkbp:bfsParent |
gptkb:Calico_(company)
|
| gptkbp:bfsLayer |
6
|